Binary relation

SEMK takes on new name "B.Duck Semk Holdings International Limited"

Retrieved on:

Wednesday, February 8, 2023

Overalls, IP, Animation, Intellectual property, Binary relation, Human, The Group, Generation Z, Growth, Gen, Motherboard, International (Amtrak train), Creativity, HKEX, IPS, Personality, Sales, Retail

In 2021, B.Duck topped all Chinese original IPs in the domestic IP licensing market in terms of revenue.

Key Points:

In 2021, B.Duck topped all Chinese original IPs in the domestic IP licensing market in terms of revenue.
It is not easy for a relatively young brand like B.Duck to earn a place in the talent-abundant IP market.
The Group will also develop a unique style guide, derivative product design, and licensing business expansion for its partners' IP.
B.Duck Semk will relentlessly make new attempts and pursue different creative tracks, in its bid to become an evergreen IP brand."

Treace Presents Updated ALIGN3D™ Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference

Retrieved on:

Thursday, February 9, 2023

American College, Patient satisfaction, Bunion, Conference, Patient, Binary relation, Guide, Pain, Medical imaging, TREAC, Foot

PONTE VEDRA, Fla., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure today announced it will highlight new interim clinical data from the ALIGN3D™ study, and recent product innovations, at the 2023 American College of Foot and Ankle Surgeons (“ACFAS”) Annual Scientific Conference in Los Angeles, California.

Key Points:

PONTE VEDRA, Fla., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure today announced it will highlight new interim clinical data from the ALIGN3D™ study, and recent product innovations, at the 2023 American College of Foot and Ankle Surgeons (“ACFAS”) Annual Scientific Conference in Los Angeles, California.
The scientific poster titled, “Three Year Interim Analysis of a Five-Year Multicenter Study Assessing Radiographic and Patient Outcomes Following Triplanar Tarsometatarsal Arthrodesis with Early Weightbearing”,1 includes an interim analysis of 128 patients from the ALIGN3D™ study with at least 24 months of follow-up following the Lapiplasty® Procedure demonstrating:
Early return to weight bearing in a walking boot at an average 8.1 days;
92% and 90% improvement in walking/standing and social interaction patient-reported quality of life measures, respectively, using the Manchester-Oxford Foot Questionnaire (MOxFQ) through 36 months (n=41); and
John T. Treace, CEO, Founder and Board Member of Treace, said, “We are excited by the updated interim results from our ALIGN3D™ study showing high patient satisfaction with rapid return to weightbearing, low recurrence rates, and significant reduction in pain and patient reported outcome scores at 24 months following the Lapiplasty® procedure.
As a company focused on improving surgical outcomes for bunion patients, we are committed to reporting the long-term results of our novel Lapiplasty® procedure though this unique 5-year, multicenter study.”
During the ACFAS Conference, Treace will feature its current and next-generation technologies at its exhibit booth including the Micro-Lapiplasty™ and SpeedPlate™ systems, which are expected to commercialize later this year.
The Company will also be hosting Lapiplasty® and Adductoplasty® surgeon hands-on training labs featuring recently commercialized innovations, including the Lapiplasty® 3-n-1™ Guide, Lapiplasty® S4A Anatomic Plating Kit, and the SpeedRelease™ and TriTome™ tissue release instruments.

HqO Releases 2023 ‘The State of Workplace Experience’ Report

Retrieved on:

Wednesday, February 1, 2023

CFOS, Environment, Charlie Leesman, Acquisition, Workplace, Learning, Binary relation, Research, Management, Restaurant

BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- HqO , the world’s leading workplace experience platform, today announced the release of its annual “ The State of Workplace Experience ” report, a research-driven analysis of how the workplace and overall employee sentiment have evolved over the past year and what trends will emerge in 2023 as more workers are called back to the office.

Key Points:

BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- HqO , the world’s leading workplace experience platform, today announced the release of its annual “ The State of Workplace Experience ” report, a research-driven analysis of how the workplace and overall employee sentiment have evolved over the past year and what trends will emerge in 2023 as more workers are called back to the office.
Highlights include:
From before the start of the pandemic to 2021-22, the percentage of respondents who said informal social interaction was an important workplace activity grew by 20%.
Survey respondents place more importance on learning from others in the workplace, moving from 39% to 42.9% over the course of the pandemic.
Click here to download the full 2023 “The State of Workplace Experience” report.

A Case For Parallel Heavens: Short Story AFTER HERE Reveals A Unique Take On The Afterlife

Retrieved on:

Wednesday, January 25, 2023

Grief, Anger, Book, Death, Loss, Student, Binary relation, Toy, Life insurance

From emotional upheavals to identifying ways to overcome life’s challenges, he has empowered students to work through their complicated feelings.

Key Points:

From emotional upheavals to identifying ways to overcome life’s challenges, he has empowered students to work through their complicated feelings.
He has even authored two books, one on anger management and one on conflict resolution, to provide children and young adults with practical strategies for social interaction.
With grief, comes feelings of insecurity and uncertainty that can be overwhelming, and oftentimes, people are plagued with questions about the afterlife.
In After Here, Dave Wolffe may have an answer for the eternal question, “Where do you go when you die?”.

SciSparc Receives Approval to Conduct its Clinical Trial in Children with Autism Spectrum Disorder at the Soroka Medical Center

Retrieved on:

Wednesday, January 18, 2023

Soroka Medical Center, Autism, Communication, Clinical Global Impression, Trial of the century, Cannabidiol, Safety, Ministry, Ethics committee, Central nervous system, Patient, Deviance (sociology), Behavior, ASD, Binary relation, TEL, Pharmaceutical industry, CBD, Health

TEL AVIV, Israel, Jan. 18, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced it has been granted an approval by the Soroka University Medical Center (“Soroka Medical Center”) to conduct its clinical study for SCI-210 in patients suffering from autism spectrum disorder ("ASD").

Key Points:

On January 9, 2023, SciSparc announced it signed an agreement with Soroka Medical Center to perform its clinical study, led by Prof. Gal Meiri, head of Soroka Medical Center’s Preschool Psychiatry Unit.
During 2022, the Company received approvals from the Israeli Ministry of Health as well as the Ethics Committee of the Soroka Medical Center to conduct the Company’s clinical trial.
The design of the study includes a 20-week, randomized double-blind placebo-controlled with cross-over clinical trial of 60 children.
The term "spectrum" in autism spectrum disorder refers to the wide range of symptoms and severity.

InventHelp Inventor Develops a Fun and Challenging New Card Game (DNV-430)

Retrieved on:

Tuesday, January 17, 2023

Sale, Friends, Multimedia, Binary relation, CARD, Publishing

PITTSBURGH, Jan. 17, 2023 /PRNewswire/ -- "I would play this card game for hours and wanted to include a new element to add an extra level of fun that also requires quick decision making and speeds up the game," said an inventor from Parker, Colo., "so I invented KNOCKERS CARD GAME."

Key Points:

PITTSBURGH, Jan. 17, 2023 /PRNewswire/ -- "I would play this card game for hours and wanted to include a new element to add an extra level of fun that also requires quick decision making and speeds up the game," said an inventor from Parker, Colo., "so I invented KNOCKERS CARD GAME."
This patent-pending invention provides a fun card game that can be played by family members and friends during leisure time, parties, and get-togethers at home.
The game is enjoyable, entertaining as well as challenging.
21-DNV-430, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

Muck Rack Names Bryan Hamblin Chief Revenue Officer

Retrieved on:

Tuesday, January 17, 2023

Muck Rack , the Public Relations Management (PRM) platform that helps organizations find the right journalists to pitch, report on media coverage, and prove the value of their work, announced today that it has appointed Bryan Hamblin Chief Revenue Officer (CRO).

Key Points:

Muck Rack , the Public Relations Management (PRM) platform that helps organizations find the right journalists to pitch, report on media coverage, and prove the value of their work, announced today that it has appointed Bryan Hamblin Chief Revenue Officer (CRO).
In this role, Bryan will lead Muck Rack’s go-to-market strategy across its Sales and Customer Success teams.
Bryan joins Muck Rack from decision intelligence company Sisu Data, where he served as Chief Revenue Officer, and was responsible for global revenue, including sales, solutions consulting, engineering, revenue operations, and customer success.
In making the announcement, Galant said, “Bryan is a proven and passionate leader who has been a catalyst for scaling founder-led companies like Muck Rack.

Survey reveals that 60% of respondents from Hong Kong want to play video games with others during Lunar New Year

Retrieved on:

Thursday, January 19, 2023

Gen, Video, Video game, Family, 2019 Lunar New Year Cup, Generation Z, Friends, YouGov, Lunar New Year, Xbox, Construction and management simulation, Baby boomers, Behavior, Bejeweled 3, Drum, Construction, Binary relation, Millennials

Overall, more Hong Kong people are choosing video games as their first choice for daily entertainment, with Generation Z and Millennials being the most likely to do so.

Key Points:

Overall, more Hong Kong people are choosing video games as their first choice for daily entertainment, with Generation Z and Millennials being the most likely to do so.
More than three quarters of respondents play video games as an entertainment activity, and more than half of them play video games at least once a week, with one-quarter playing once a day or more frequently.
The survey also revealed that Hong Kong video game players prefer games that are simple to play, are multiplayer, are entertaining, and are also interactive.
The survey found that 66% of gamers prefer to play video games with others over the Lunar New Year break.

Zynerba Pharmaceuticals Announces Publication in the Journal of Neurodevelopmental Disorders Describing the Role of the Endocannabinoid System and Cannabidiol Therapy in Fragile X Syndrome

Retrieved on:

Wednesday, January 11, 2023

CONNECT, Neurodevelopmental disorder, Cannabidiol, Methylation, FMR1, Patient, Fragile X syndrome, Journal, FMRP, ECS, Irritability, Endocannabinoid system, Binary relation, Journal of Neurodevelopmental Disorders, FXS, Medical device, Pharmaceutical industry, Jean-François Zygel

DEVON, Pa., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announces the publication of a paper entitled, “Role of the Endocannabinoid System in Fragile X Syndrome: Potential Mechanisms for Benefit From Cannabidiol Treatment,” in the Journal of Neurodevelopmental Disorders. The review of evidence suggests a central role for the endocannabinoid system (ECS) in neuronal development and cognitive function and in the pathogenesis of Fragile X syndrome (FXS), and the potential role of cannabidiol as a treatment for FXS. The article can be accessed online at the Journal of Neurodevelopmental Disorders at https://rdcu.be/c25fu.

Key Points:

The review of evidence suggests a central role for the endocannabinoid system (ECS) in neuronal development and cognitive function and in the pathogenesis of Fragile X syndrome (FXS), and the potential role of cannabidiol as a treatment for FXS.
The article can be accessed online at the Journal of Neurodevelopmental Disorders at https://rdcu.be/c25fu .
“This publication describes the potential of Zygel as a treatment for Fragile X syndrome based on the central role the endocannabinoid system plays in neuronal development and function,” said Armando Anido, Chairman and Chief Executive Officer of Zynerba.
Cannabidiol may help restore the function of the ECS in FXS according to a review of data to date.

SciSparc Signs Agreement to Conduct its Clinical Trial in Autism Spectrum Disorder with Soroka Medical Center

Retrieved on:

Monday, January 9, 2023

TEL AVIV, Israel, Jan. 09, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced it has signed an agreement with the Soroka University Medical Center, in Be'er-Sheva, Israel ("Soroka Medical Center") to conduct the Company’s clinical study for SCI-210 in patients suffering from autism spectrum disorder ("ASD").

Key Points:

During 2022, the Company received approvals from the Israeli Ministry of Health as well as the Ethics Committee of the Soroka University Medical Center, in Be'er-Sheva, Israel, to conduct the Company’s clinical trial.
“The signing of the agreement with Soroka Medical Center represents another step towards commencing our clinical trial in ASD,” commented Oz Adler, SciSparc's Chief Executive Officer.
Soroka Medical Center is yet another example for our continuous efforts to collaborate with leading medical institutions in the world."
The term "spectrum" in autism spectrum disorder refers to the wide range of symptoms and severity.